Mordor Intelligence has published a new report on the nuclear medicine radioisotopes market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Nuclear Medicine Radioisotopes Market Analysis
According to Mordor Intelligence, the nuclear medicine radioisotopes market size is valued at USD 6.52 billion in 2024 and is projected to reach USD 9.24 billion by 2029, growing at a CAGR of 7.23% during the forecast period. The nuclear medicine radioisotopes market continues to expand as healthcare systems increasingly rely on molecular imaging and targeted radionuclide therapy for the diagnosis and management of chronic diseases.
The nuclear medicine radioisotopes industry plays a central role in oncology, cardiology, and neurology. Radioisotopes are widely used in diagnostic imaging techniques such as positron emission tomography and single-photon emission computed tomography, enabling physicians to detect and monitor disease progression with greater accuracy. Growing awareness of early disease detection is supporting steady nuclear medicine radioisotopes market growth.
Nuclear Medicine Radioisotopes Market Trends
Rising Burden of Cancer and Cardiovascular Diseases
One of the most significant nuclear medicine radioisotopes market trends is the increasing incidence of cancer and cardiovascular conditions. Diagnostic imaging plays a critical role in staging cancer, assessing metastasis, and monitoring treatment response. Radioisotopes are integral to these procedures, reinforcing nuclear medicine radioisotopes market share within diagnostic departments.
Growing Adoption of Targeted Radionuclide Therapy
Another key nuclear medicine radioisotopes market trend is the expanding use of therapeutic radioisotopes in oncology. Targeted radionuclide therapies deliver radiation directly to cancer cells while minimizing damage to surrounding tissues. This approach has gained traction in managing certain tumor types.
The increasing clinical use of therapeutic isotopes strengthens nuclear medicine radioisotopes market size and broadens application areas. As treatment protocols evolve, the nuclear medicine radioisotopes industry is witnessing greater integration of diagnostic and therapeutic applications.
Expansion of Imaging Infrastructure
Hospitals and diagnostic centers are investing in advanced imaging systems, including positron emission tomography and single-photon emission computed tomography scanners. This infrastructure development supports higher procedure volumes and reinforces nuclear medicine radioisotopes market growth.
Emerging economies are gradually improving access to nuclear medicine facilities, which enhances the nuclear medicine radioisotopes market forecast across Asia-Pacific, Latin America, and parts of the Middle East.
Focus on Reliable Isotope Supply Chains
The nuclear medicine radioisotopes industry depends on reliable production and distribution networks. Efforts to strengthen reactor capacity, cyclotron installations, and supply logistics are shaping nuclear medicine radioisotopes market trends. Ensuring consistent availability of commonly used isotopes remains a priority for healthcare systems and manufacturers alike.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/global-nuclear-medicine-radioisotopes-market-industry?utm_source=emailwire
Nuclear Medicine Radioisotopes Market Segmentation Overview
The nuclear medicine radioisotopes market is segmented by type, application, end user, and geography. These segments reflect the wide-ranging clinical use of radioisotopes within the nuclear medicine radioisotopes industry.
By Type
- Diagnostic Radioisotopes
- Technetium-99m (Tc-99m)
- Therapeutic Radioisotopes
By Application
By Source
- Reactor-Produced Isotopes
- Cyclotron-Produced Isotopes
- Generator-Produced Isotopes
By End User
- Diagnostic Imaging Centers
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
By Geography
- Rest of Middle East and Africa
Explore Our Full Library of Healthcare Research Report: https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=emailwire
Key Players in the Nuclear Medicine Radioisotopes Industry
The nuclear medicine radioisotopes industry includes companies engaged in isotope production, distribution, and radiopharmaceutical development. These organizations operate reactors and cyclotrons and collaborate with healthcare providers to ensure timely supply.
Key companies include:
- Sotera Health Company (Nordion Inc.)
- NECSA Ltd. (NTP Radioisotopes SOC Ltd.)
- NorthStar Medical Radioisotopes LLC
Conclusion – Nuclear Medicine Radioisotopes Market Outlook
The nuclear medicine radioisotopes market forecast indicates steady expansion driven by increasing diagnostic imaging needs and growing use of targeted radionuclide therapies. As cancer and chronic disease cases continue to rise, nuclear medicine procedures are expected to remain integral to patient management.
The nuclear medicine radioisotopes industry is likely to benefit from expanding imaging infrastructure and stronger isotope production capabilities. Providers that focus on reliable supply, regulatory adherence, and clinical collaboration are well positioned to support ongoing nuclear medicine radioisotopes market growth.
Industry Related Reports
North America Nuclear Medicine Market Size
The North America nuclear medicine market is projected to grow from USD 8.22 billion in 2026 to USD 16.38 billion by 2031, registering a CAGR of 14.78% during the forecast period. Growth is driven by increasing adoption of radiopharmaceuticals in oncology and cardiology, expanding PET and SPECT imaging applications, and rising investments in advanced diagnostic infrastructure across the region.
Alpha Emitter Market Growth
The alpha emitter market is expected to increase from USD 920 million in 2026 to USD 1.57 billion by 2031, growing at a CAGR of 11.28%. Market expansion is supported by growing research in targeted alpha therapy, rising demand for precision oncology treatments, and increased clinical development of radioligand therapies.
Global Spinal Imaging Treatment Market Share
The global spinal imaging treatment market is anticipated to register a CAGR of 5.2% during the forecast period. Growth is driven by the rising prevalence of spinal disorders, increasing demand for early diagnostic imaging, and expanding use of advanced imaging modalities in orthopedic and neurological care.
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
